Press release
April 14, 2026
Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel
Structure Therapeutics Inc. (GPCR)
SAN FRANCISCO, April 14, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced the appointment of Matthew Lang, J.D.